Ahmet Özen - Concepedia

Author

Ahmet Özen

Also Known As

A Ozen, A. O. Özen, A. Ozen, A. Özen, AHMET OZEN, Ahmet O. Ozen, Ahmet OZEN, Ahmet Oguzhan Ozen, Ahmet Ozen, Ahmet Oğuzhan Özen

253

Publications

5.4K

Citations

H-Index

120

Concepts

All Affiliations

Marmara University Boston Children's Hospital Harvard University National Institute of Allergy and Infectious Diseases National Institutes of Health

AÖ

About

Ahmet Özen is an author at Marmara University specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	1.7K
2	Health Sciences	7	7	190
3	Education	1	1	21
4	Natural Sciences	1	1	20
5	Public Health	1	1	21

Ahmet Özen

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study Isabelle Meyts, Giorgia Bucciol, Isabella Quinti, Journal of Allergy and Clinical Immunology	2020	358
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study Federica Barzaghi, Laura Amaya, Bénédicte Neven, Journal of Allergy and Clinical Immunology	2017	301
Heterozygous splice mutation in <i>PIK3R1</i> causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K C. Lucas, Yu Zhang, Anthony Venida, The Journal of Experimental Medicine	2014	279
Mucus sialylation determines intestinal host-commensal homeostasis Yikun Yao, Girak Kim, Samantha Shafer, Cell Mucosal ImmunologyMucus SialylationPathogenesisImmunologyGastroenterology	2022	211
CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis Ahmet Özen, William A. Comrie, Rico Chandra Ardy, New England Journal of Medicine	2017	187
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity Vivien Béziat, Juan Li, Jian‐Xin Lin, Science Immunology	2018	186
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, Frontiers in Immunology	2018	176
Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency İsmail Öğülür, Esra Dursun, Louis‐Marie Charbonnier, The Journal of Allergy and Clinical Immunology In Practice Autoimmune DiseaseNovel TherapyImmunologyClinical TrialsAntisense Therapy	2019	153
Functional reprogramming of regulatory T cells in the absence of Foxp3 Louis‐Marie Charbonnier, Ye Cui, Emmanuel Stephen‐Victor, Nature Immunology	2019	137
Therapeutic options for CTLA-4 insufficiency David Egg, Ina Caroline Rump, Noriko Mitsuiki, Journal of Allergy and Clinical Immunology Translational MedicineCtla-4 InsufficiencyAutoimmune DiseaseImmunosuppressive TherapyImmunology	2021	114

Page 1